|
US4570630A
(en)
*
|
1983-08-03 |
1986-02-18 |
Miles Laboratories, Inc. |
Medicament inhalation device
|
|
US5161524A
(en)
*
|
1991-08-02 |
1992-11-10 |
Glaxo Inc. |
Dosage inhalator with air flow velocity regulating means
|
|
US6582728B1
(en)
|
1992-07-08 |
2003-06-24 |
Inhale Therapeutic Systems, Inc. |
Spray drying of macromolecules to produce inhaleable dry powders
|
|
GB9216038D0
(en)
*
|
1992-07-28 |
1992-09-09 |
Bespak Plc |
Dispensing apparatus for powdered medicaments
|
|
NZ262807A
(en)
*
|
1993-03-03 |
1997-11-24 |
Glaxo Wellcome Inc |
Inhalator; medicament carrier for dry powder inhalator has a portion with a plurality of interstices, for a predetermined dose
|
|
US5388572A
(en)
*
|
1993-10-26 |
1995-02-14 |
Tenax Corporation (A Connecticut Corp.) |
Dry powder medicament inhalator having an inhalation-activated piston to aerosolize dose and deliver same
|
|
US5388573A
(en)
*
|
1993-12-02 |
1995-02-14 |
Tenax Corporation |
Dry powder inhalator medicament carrier
|
|
US5505194A
(en)
*
|
1994-03-23 |
1996-04-09 |
Abbott Laboratories |
Aerosol inhalation device having slideably and rotatably connected elliptical cylinder portions
|
|
US6290991B1
(en)
|
1994-12-02 |
2001-09-18 |
Quandrant Holdings Cambridge Limited |
Solid dose delivery vehicle and methods of making same
|
|
FR2731911B1
(fr)
*
|
1995-03-20 |
1997-08-14 |
Paul Seyvos |
Dispositif qui permet d'inhaler, par la bouche, l' odeur de produits contenus dans un reservoir a des fins therapeutiques
|
|
CA2239292C
(fr)
|
1995-12-07 |
2003-09-30 |
Jago Pharma Ag |
Inhalateur fournissant des doses multiples d'une poudre seche pharmacologique
|
|
US7131441B1
(en)
|
1995-12-07 |
2006-11-07 |
Skyepharma Ag |
Inhaler for multiple dosed administration of a pharmacological dry powder
|
|
US5669378A
(en)
*
|
1995-12-21 |
1997-09-23 |
Pera; Ivo |
Inhaling device
|
|
US20030203036A1
(en)
|
2000-03-17 |
2003-10-30 |
Gordon Marc S. |
Systems and processes for spray drying hydrophobic drugs with hydrophilic excipients
|
|
CA2212430A1
(fr)
*
|
1997-08-07 |
1999-02-07 |
George Volgyesi |
Appareil inhalateur
|
|
UA73924C2
(en)
*
|
1998-10-09 |
2005-10-17 |
Nektar Therapeutics |
Device for delivering active agent formulation to lungs of human patient
|
|
DE29908593U1
(de)
|
1999-05-14 |
1999-07-22 |
Jago Research AG, Hergiswil |
Mundstück für einen Inhalator zur Abgabe eines Medikaments
|
|
CN100341483C
(zh)
|
2000-02-28 |
2007-10-10 |
维克丘拉有限公司 |
口服药物输递中或涉及口服药物输递的改进
|
|
US6595210B2
(en)
*
|
2000-11-27 |
2003-07-22 |
Unisia Jecs Corporation |
Inhalator for administering powder composition
|
|
GB2380410B
(en)
*
|
2001-10-05 |
2003-11-19 |
Alchemy Healthcare Ltd |
Apparatus for the nasal or oral delivery of a medicament
|
|
US7794965B2
(en)
|
2002-03-13 |
2010-09-14 |
Signum Biosciences, Inc. |
Method of identifying modulators of PP2A methylase
|
|
ITMO20020297A1
(it)
*
|
2002-10-16 |
2004-04-17 |
Roberto Oliva |
Inalatore per preparati monodose in capsule.
|
|
US20060045849A1
(en)
*
|
2004-08-24 |
2006-03-02 |
Farhan Taghizadeh |
Method of customizing the fragrance of nasal medications
|
|
PL370285A1
(pl)
*
|
2004-09-23 |
2006-04-03 |
Glaxosmithkline Pharmaceuticals Spółka Akcyjna |
Inhalator proszkowy
|
|
WO2006084033A1
(fr)
|
2005-02-03 |
2006-08-10 |
Signum Biosciences, Inc. |
Compositions et procedes pour l'amelioration de la fonction cognitive
|
|
US7923041B2
(en)
|
2005-02-03 |
2011-04-12 |
Signum Biosciences, Inc. |
Compositions and methods for enhancing cognitive function
|
|
US9345745B2
(en)
*
|
2005-04-29 |
2016-05-24 |
Bo Wang |
Methods for treating inflammatory disorders and traumatic brain injury using stabilized non-hematopoietic EPO short peptides
|
|
WO2007052154A2
(fr)
*
|
2005-04-29 |
2007-05-10 |
University Of Medicine And Dentistry Of New Jersey |
Peptide court derive d'erythropoietine et ses mimetiques utilises comme modulateurs immuno / inflammatoires
|
|
US9585932B2
(en)
|
2005-04-29 |
2017-03-07 |
Peter C. Dowling |
Use of EPO-derived peptide fragments for the treatment of neurodegenerative disorders
|
|
CA2620123C
(fr)
*
|
2005-08-24 |
2011-11-22 |
The Board Of Trustees Of The Leland Stanford Junior University |
Methodes de traitement et de surveillance de l'inflammation et du desequilibre d'oxydoreduction dans la mucoviscidose
|
|
US20090192227A1
(en)
*
|
2005-08-24 |
2009-07-30 |
Rabindra Tirouvanziam |
N-Acetylcysteine Compositions and Methods for Treating Acute Exacerbations of Inflammatory Lung Disease
|
|
US8227408B2
(en)
*
|
2005-09-07 |
2012-07-24 |
Neurotez, Inc. |
Leptin as an anti-amyloidogenic biologic and methods for delaying the onset and reducing Alzheimer's disease-like pathology
|
|
US9107824B2
(en)
|
2005-11-08 |
2015-08-18 |
Insmed Incorporated |
Methods of treating cancer with high potency lipid-based platinum compound formulations administered intraperitoneally
|
|
GB0604444D0
(en)
|
2006-03-06 |
2006-04-12 |
Optinose As |
Nasal devices
|
|
EP2155228B1
(fr)
*
|
2007-01-10 |
2014-04-02 |
Purdue Research Foundation |
Inhibiteurs polypeptidiques de la hsp27 kinase et leurs utilisations
|
|
ES2547229T3
(es)
|
2007-08-07 |
2015-10-02 |
Purdue Research Foundation |
Inhibidores de cinasa y usos de los mismos
|
|
EP3272379A1
(fr)
|
2008-02-07 |
2018-01-24 |
The University of Washington |
Dispositif aérosol circonférentiel
|
|
EP2326339A4
(fr)
*
|
2008-05-21 |
2012-06-20 |
Neurotez Inc |
Procédés de traitement de troubles cognitifs progressifs liés à la dégénérescence neurofibrillaire
|
|
PL2293833T3
(pl)
*
|
2008-06-13 |
2016-08-31 |
Mannkind Corp |
Inhalator proszkowy i układ do dostarczania leku
|
|
CA2741302C
(fr)
*
|
2008-10-20 |
2017-02-28 |
Moerae Matrix, Inc. |
Polypeptide inhibiteur de la kinase mapkap destine au traitement ou a la prevention des adherences
|
|
WO2010054017A1
(fr)
*
|
2008-11-04 |
2010-05-14 |
Nikolaos Tezapsidis |
Compositions à base de leptine et méthodes de traitement de troubles évolutifs de la fonction cognitive provoqués par une accumulation d’enchevêtrements neurofibrillaires et de bêta-amyloïde
|
|
KR101965255B1
(ko)
*
|
2008-12-10 |
2019-04-03 |
퍼듀 리서치 파운데이션 |
키나아제의 세포-침투성 펩티드-기초된 저해물질
|
|
BR112012002183A2
(pt)
|
2009-07-24 |
2016-05-31 |
Amazentis Sa |
compostos, composições e métodos para proteger a saúde do cérebro em transtornos neurodegenerativos
|
|
WO2011017132A2
(fr)
*
|
2009-07-27 |
2011-02-10 |
Purdue Research, Foundation |
Compositions d'inhibiteurs de mk2 et procédés d'amélioration de l'excroissance des neurites, de la neuroprotection et de la régénération des nerfs
|
|
RU2612506C2
(ru)
|
2011-03-03 |
2017-03-09 |
Импел Ньюрофарма Инк. |
Устройство для назальной доставки лекарственных средств
|
|
SG194135A1
(en)
|
2011-04-12 |
2013-11-29 |
Matrix Inc Moerae |
Compositions and methods for preventing or treating diseases, conditions, or processes characterized by aberrant fibroblast proliferation and extracellular matrix deposition
|
|
US9890200B2
(en)
|
2011-04-12 |
2018-02-13 |
Moerae Matrix, Inc. |
Compositions and methods for preventing or treating diseases, conditions, or processes characterized by aberrant fibroblast proliferation and extracellular matrix deposition
|
|
US9579337B2
(en)
|
2011-04-25 |
2017-02-28 |
Cornell University |
Use of uridine and deoxyuridine to treat folate-responsive pathologies
|
|
CA2835208C
(fr)
|
2011-05-09 |
2019-08-20 |
Impel Neuropharma, Inc. |
Buses pour l'administration de medicaments par voie nasale
|
|
EP2589381B1
(fr)
|
2011-11-04 |
2016-08-31 |
Rabindra Tirouvanziam |
Compositions pour améliorer ou préserver une fonction de poumons chez un patient souffrant de troubles pulmonaires
|
|
WO2013134636A1
(fr)
|
2012-03-09 |
2013-09-12 |
Purdue Research Foundation |
Compositions et procédés d'administration de peptides inhibiteurs de kinases
|
|
EP2892524B1
(fr)
|
2012-09-04 |
2020-11-25 |
Eleison Pharmaceuticals, LLC |
Prévention de la rechute du cancer pulmonaire avec un complexe lipide/cisplatine
|
|
CA2909954C
(fr)
|
2013-04-28 |
2021-03-23 |
Impel Neuropharma, Inc. |
Flacon a dose unitaire medical
|
|
WO2015006639A1
(fr)
|
2013-07-12 |
2015-01-15 |
SILVA, John, H. |
Pièce buccale pour inhalateur
|
|
WO2015038644A2
(fr)
|
2013-09-10 |
2015-03-19 |
Debrabander Jef |
Thérapie ciblant des protéines polypose adénomateuse familiale (apc) tronquées
|
|
US10336788B2
(en)
|
2014-04-17 |
2019-07-02 |
Moerae Matrix, Inc. |
Inhibition of cardiac fibrosis in myocardial infarction
|
|
USD748242S1
(en)
|
2014-07-11 |
2016-01-26 |
H. Stuart Campbell |
Inhaler mouthpiece
|
|
US10082496B2
(en)
|
2014-09-10 |
2018-09-25 |
Board Of Regents Of The University Of Texas System |
Targeting emopamil binding protein (EBP) with small molecules that induce an abnormal feedback response by lowering endogenous cholesterol biosynthesis
|
|
AU2015350151A1
(en)
|
2014-11-17 |
2017-06-01 |
Moerae Matrix, Inc. |
Compositions and methods for preventing or treating diseases, conditions, or processes characterized by aberrant fibroblast proliferation and extracellular matrix deposition
|
|
JP6921755B2
(ja)
|
2014-12-10 |
2021-08-18 |
ハイパーステム ソシエテ アノニム |
脳腫瘍幹細胞の成長、遊走および浸潤性を低下させ脳腫瘍患者の生存率を改善する方法および組成物
|
|
EP3242886A4
(fr)
|
2015-01-08 |
2018-08-29 |
Moerae Matrix, Inc., |
Formulation de peptides inhibiteurs de mk2
|
|
CN107921082A
(zh)
|
2015-03-12 |
2018-04-17 |
莫伊莱麦屈克斯公司 |
含有mk2抑制剂肽的组合物用于治疗非小细胞肺癌的用途
|
|
CA2987071A1
(fr)
|
2015-06-10 |
2016-12-15 |
Hackensack University Medical Center |
Utilisation du telmisartan pour la prevention et le traitement de la maladie du greffon contre l'hote et d'autres maladies auto-immunes et allo-immunes
|
|
WO2017007634A1
(fr)
|
2015-07-06 |
2017-01-12 |
The Board Of Regents Of The University Of Texas System |
Composés benzamide ou benzamine à utiliser en tant qu'anticancéreux pour le traitement de cancers humains
|
|
EP3322417B1
(fr)
|
2015-07-15 |
2023-08-23 |
The Board of Regents of The University of Texas System |
Ciblage de protéine de liaison de l'emopamil (ebp) avec de petites molécules qui induisent une réponse de rétroaction anormale par l'abaissement de la biosynthèse du cholestérol endogène
|
|
US11266799B2
(en)
|
2015-09-10 |
2022-03-08 |
Impel Neuropharma, Inc. |
In-line nasal delivery device
|
|
EP3405175A4
(fr)
|
2016-01-20 |
2019-09-25 |
Flurry Powders, LLC |
Encapsulation d'ingrédients lipophiles dans des poudres séchées par pulvérisation pouvant être dispersées destinées à l'inhalation
|
|
US11833118B2
(en)
|
2016-01-20 |
2023-12-05 |
Flurry Powders, Llc |
Encapsulation of lipophilic ingredients in dispersible spray dried powders suitable for inhalation
|
|
CA3081680A1
(fr)
|
2017-11-21 |
2019-05-31 |
Impel Neuropharma, Inc. |
Dispositif intra-nasale avec interface d'entree
|
|
WO2019104205A1
(fr)
|
2017-11-21 |
2019-05-31 |
Impel Neuropharma, Inc. |
Dispositif intra-nasal avec tube plongeur
|
|
AU2019205318B2
(en)
|
2018-01-05 |
2022-02-03 |
Impel Pharmaceuticals Inc. |
Intranasal delivery of dihydroergotamine by precision olfactory device
|
|
WO2019136308A1
(fr)
|
2018-01-05 |
2019-07-11 |
Impel Neuropharma, Inc. |
Administration intranasale d'olanzapine par un dispositif olfactif de précision
|
|
US11517548B2
(en)
|
2018-07-19 |
2022-12-06 |
Impel Pharmaceuticals Inc. |
Respiratory tract delivery of levodopa and DOPA decarboxylase inhibitor for treatment of Parkinson's Disease
|
|
KR20210109007A
(ko)
|
2019-01-03 |
2021-09-03 |
임펠 뉴로파마 인코포레이티드 |
비강 약물 전달 장치
|
|
CN114025816A
(zh)
|
2019-05-17 |
2022-02-08 |
英倍尔药业股份有限公司 |
一次性鼻腔给送装置
|